Expert answers to your most frequently asked questions about hormone therapy, ED, supplements, peptides, and longevity medicine.
Men's Health FAQ
Expert answers to your most frequently asked questions about hormone therapy, ED, supplements, peptides, and longevity medicine.
This content is for educational purposes only and does not constitute medical advice or replace individual clinical consultation. All treatment decisions require physician evaluation. Many answers below depend on individual clinical factors that cannot be fully addressed without a proper medical assessment.
Men's Health & Wellness FAQ
The questions patients ask most frequently about hormone therapy, testosterone, erectile dysfunction, supplements, peptides, and longevity medicine often reflect a mix of genuine medical curiosity, misinformation circulating online, and anxiety about treatments that are widely marketed but poorly understood. This FAQ page provides evidence-based answers to the questions we hear most often at Advanced Vitality Group — grounded in published clinical trial data, established medical guidelines, and the same evidence standard we apply to all our clinical programs.
These answers are educational and reflect the current clinical and scientific consensus. They are not medical advice and do not substitute for an individualized clinical evaluation.
Testosterone & Hormone Therapy
Erectile Dysfunction
Creatine & Supplements
Peptides
Longevity & Prevention
Scientific References
- Endocrine Society. “Testosterone Therapy in Men with Hypogonadism.” JCEM. 2018;103(5):1715–1744.
- American Urological Association. “Testosterone Deficiency Guideline.” 2022.
- Lincoff AM, et al. “Cardiovascular safety of TRT (TRAVERSE).” NEJM. 2023;389(2):107–117.
- Burnett AL, et al. “Erectile Dysfunction: AUA Guideline.” Journal of Urology. 2018;200(3):633–641.
- Kreider RB, et al. “ISSN position stand: safety and efficacy of creatine supplementation.” JISSN. 2017;14:18.
- Bhatt DL, et al. “Cardiovascular risk reduction with icosapentaenoic acid (REDUCE-IT).” NEJM. 2019;380(1):11–22.
- Yoshino M, et al. “Nicotinamide mononucleotide increases muscle insulin sensitivity.” Science. 2021.
- Lee DH, et al. “Leisure-time physical activity and all-cause mortality.” JAMA Internal Medicine. 2022.
- Barzilai N, et al. “Metformin as a Tool to Target Aging.” Cell Metabolism. 2016;23(6):1060–1065.
- FDA. “October 2024 Meeting of the Pharmacy Compounding Advisory Committee — ipamorelin.” FDA.gov. 2024.
Schedule a consultation with our physician-supervised team.